43.

The Respondent also has a note from a cardiologist from May 11, 2018,

where the cardiologist discontinued Patient 10’s Adderall XR 30 mg BID. The

Respondent’s notes stated that Patient 10 was continuing to take both Adderall and

Mydayis after this visit, however. Although the Respondent discussed Patient 10’s use of

stimulants, he did not follow the cardiologist’s recommendation.

44.

The Respondent failed to meet appropriate standards for the delivery of

quality. medical care, in violation of Health Occ. § 14-404(a)(22), and failed to keep

adequate medical records, in violation of Health Occ. § 14-404(a)(40), with respect to

Patient 10, for reasons including:

(a)

(b)

(c)

(d)

(¢)

(f)

the Respondent failed to document or consider a diagnosis of personality
disorder;

the Respondent maintained Patient 10 on an excessive dosage of Cymbalta,
with no further benefit warranting its continuation at this dosage;

the Respondent continued Patient 10 on redundant stimulants after Patient
10’s cardiologist discontinued her Adderall;

the Respondent did not document or address Patient 10’s use of caffeine
pills;

the Respondent maintained Patient 10 on excessive doses of stimulants
after Patient 10 reported palpitations to her cardiologist, who recommended
discontinuation of Adderall;

the Respondent did not document or undertake metabolic monitoring when

prescribing an antipsychotic (Abilify); and

22
